J Korean Soc Spine Surg. 2001 Sep;8(3):372-377. Korean.
Published online Sep 30, 2001.
Copyright © 2001 Korean Society of Spine Surgery
Review

Growth Factors and Their Clinical Applications

Seong-Hwan Moon, M.D., Hak-Sun Kim, M.D. and Hwan-Mo Lee, M.D.
    • Department of Orthopedic Surgery, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Growth factor is a polypeptide regulating cell proliferation, maturation, activity, and apoptosis. Despite its small molecular weight, it exerts diverse and potent biologic effects on cellular function. With recent development of molecular biology and vector technology, it is now possible to administer recombinant growth factors in clinical dose and modify somatic cell with growth factor encoding gene. Research fields in spinal surgery can be divided into spinal fusion, disc regeneration and spinal cord regeneration. In this review, we discuss the action mechanism of growth factors and their possible clinical applications especially in the field of spinal fusion and disc regeneration.

Keywords
Growth factor; Spinal fusion; Disc degeneration

Tables

Table 1
Abbreviation used in the text

References

    1. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25(3):376–381.
    1. Grauer JN, Patel TC, Erulkar JS, Troiano NW, Panjabi MM, Friedlaender GE. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2000;26(2):127–133.
    1. Grimsrud CD, Romano PR, D'Souza M, Puzas JE, Schwarz EM, Reynolds PR, Roiser RN, O'Keefe RJ. BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog. J Orthop Res 2001;19(1):18–25.
    1. Gruber HE, Fisher EC Jr, Desai B, Stasky AA, Hoelscher G, Hanley EN Jr. Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Exp Cell Res 1997;235(1):13–21.
    1. Gruber HE, Norton HJ, Hanley EN Jr. Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine 2000;25(17):2153–2157.
    1. Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B. BMP-2 induction and TGF-beta1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 2001;81(2):284–294.
    1. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000;100:57–70.
    1. Helm GA, Alden TD, Beres EJ, Hudson SB, Das S, Engh JA, Pittman DD, Kerns KM, Kallmes DF. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 2000;92 2 Suppl:191–196.
    1. Hunter T. Signalling-2000 and beyond. Cell 2000;100:113–127.
    1. Itoh S, Itoh F, Goumans M-J, Dijke PT. Signalling of transforming growth factor-β family members through Smad protein. Eur J Biochem 2000;267:6954–6967.
    1. Jeppsson C, Saveland H, Rydholm U, Aspenberg P. OP-1 for cervical spine fusion : bridging bone in only 1 of 4 rheumatoid patients but prednisolone did not inhibit bone induction in rats. Acta Orthop Scand 1999;70(6):559–563.
    1. Laursen M, Hoy K, Hansen ES, Gelineck J, Christensen FB, Bunger CE. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 1999;8(6):485–490.
    1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154–1162.
    1. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone 1999;25 2 Suppl:47S–50S.
    1. Magin MN, Delling G. Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite(Bio-Oss), and BMP-7(rhOP-1) in sheep. Spine 2001;26(5):469–478.
    1. Moon SH, Gilbertson LG, Nishida K, Knaub MA, Muzzonigro T, Robbins PD, Evans CH, Kang JD. Human interverterbal disc cells are genetically modifiable by adenovirus-mediated gene transfer. Spine 2000;25:2573–2579.
    1. Moon SH, Kang JD, Nishida K, Gilbertson LG, Niyibizi C, Smith PN, Knaub MA, Robbins PD, Evans CH. Human cervical intervertebral disc cells are susceptible to adenovirus-mediated gene therapy -Therapeutic gene transfer-; Proceedings of 27th annual meeting, Cervical Spine Research Society; 1999. pp. 150-153.
    1. Moon SH, Lee HM, Park MS, Kim H, Kang ES, Kim HS, Gilbertson LG, Kang JD. BMP-2 upregulate the mRNA expression of aggrecan, collagen type I, collagen type II in human interverterbal disc cells. Orthopaedic Research Society. 2002
      (Submitted).
    1. Moon SH, Nishida K, Gilbertson LG, Hall RA, Robbins PD, Kang JD. Biologic response of human interverterbal disc cells to gene therapy cocktail; Proceedings of Orthopaedic Research Society; 2000.
    1. Moon SH, Nishida K, Gilbertson LG, Knaub MA, Smith PN, Robbins PD, Evans CH, Kang JD. Proteoglycan synthesis in human intervertebral disc cells cultured in alginate beads: Exogenous TGF-beta1 vs. adenovirus-mediated gene transfer of TGF-beta1 cDNA; Proceedings of Orthopaedic Research Society; 2000.
    1. Monroe MA, Boden SD, Hair G, Martin GJ Jr, Racine M, Titus L, Hutton WC. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. Clin Orthop 1998;351:252–265.
    1. Muschik M, Schlenzka D, Ritsila V, Tennstedt C, Lewandrowski KU. Experimental anterior spine fusion using bovine bone morphogenetic protein: a study in rabbits. J Orthop Sci 2000;5(2):165–170.
    1. Muschler GF, Hyodo A, Manning T, Kambic H, Easley K. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 1994;308:229–240.
    1. Nishida K, Kang JD, Suh J-K, Robbins PD, Evans CH, Gilbertson LG. Adenovirus-mediated gene transfer to nucleus pulposus cells: Implication for the treatment of intervertebral disc degeneration. Spine 1998;23:2437–2443.
    1. Nishida K, Kang JD, Gilbertson LG, Moon S-H, Suh JK, Vogt MT, Robbins PD, Evans CH. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor β1 encoding gene. Spine 1999;24:2419–2425.
    1. Osada R, Ohshima H, Ishihara H, Yudoh K, Sakai K, Matsui H, Tsuji H. Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J Orthop Res 1996;14(5):690–699.
    1. Riew KD, Wright NM, Cheng S, Avioli LV, Lou J. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 1998;63(4):357–360.
    1. Sandhu HS. Anterior lumbar interbody fusion with osteoinductive growth factors. Clin Orthop 2000;371:56–60.
    1. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20(12):1326–1337.
    1. Smith P, Shuler FD, Georgescu HI, Ghivizzani SC, Johnstone B, Niyibizi C, Robbins PD, Evans CH. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 2000;43(5):1156–1164.
    1. Solheim E. Osteoinduction by demineralised bone. Int Orthop 1998;22(5):335–342.
    1. Thompson JP, Oegema TR Jr, Bradford DS. Stimulation of mature canine intervertebral disc by growth factors. Spine 1991;16(3):253–260.
    1. Viggeswarapu M, Boden SD, Liu Y, Hair GA, Lois-Ugbo J, Murakami H, Kim H-S, Mayr MT, Hutton WC, Titus L. Adenoviral delivery of LIM mineralization protein-1 induces new bone formation in vitro and in vivo. J Bone Joint Surg Am 2001;83:364–376.

Metrics
Share
Tables

1 / 1

PERMALINK